릴리 비만치료제 알약 FDA 승인…149달러 가격 파괴 분석 – 글로벌이코노믹
The U.S. Food and Drug Administration has granted approval for Eli Lilly’s novel oral GLP-1 receptor agonist, marking a pivotal shift in obesity management. Priced at approximately $149 monthly, this ... Read More